Cancer of unknown primary origin primary prevention: Difference between revisions
Farima Kahe (talk | contribs) Created page with "__NOTOC__ {{Cancer of unknown primary origin}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the primary prevention of [disease name]. OR There are no..." |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There are no | There are no primary [[Prevention (medical)|preventive measures]] available for cancer of unknown primary origin. | ||
==Primary Prevention== | ==Primary Prevention== | ||
There are no | There are no primary preventive measures available for cancer of unknown primary origin.<ref name="pmid15888766">{{cite journal |vauthors=Briasoulis E, Tolis C, Bergh J, Pavlidis N |title=ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of cancers of unknown primary site (CUP) |journal=Ann. Oncol. |volume=16 Suppl 1 |issue= |pages=i75–6 |year=2005 |pmid=15888766 |doi=10.1093/annonc/mdi804 |url=}}</ref> | ||
[ | There is no [[evidence]] that follow-up of [[asymptomatic]] [[patients]] is needed.<ref name="pmid15888766" /> | ||
==References== | ==References== |
Latest revision as of 23:22, 22 October 2019
Cancer of unknown primary origin Microchapters |
Differentiating Cancer of Unknown Primary Origin from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cancer of unknown primary origin primary prevention On the Web |
American Roentgen Ray Society Images of Cancer of unknown primary origin primary prevention |
Cancer of unknown primary origin primary prevention in the news |
Blogs on Cancer of unknown primary origin primary prevention |
Risk calculators and risk factors for Cancer of unknown primary origin primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no primary preventive measures available for cancer of unknown primary origin.
Primary Prevention
There are no primary preventive measures available for cancer of unknown primary origin.[1]
There is no evidence that follow-up of asymptomatic patients is needed.[1]